Search

Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More

BIO ROUNDUP: DRUG PRICES, CRISPR CAVEATS, RUBIUS IPO POP & MORE

After nearly two years of all smoke, no fire around President Trump's promise to curtail drug prices, there's finally some glimmer...

 
 
 

EVOTEC SEALS DEAL FOR SANOFI'S INFECTIOUS DISEASE UNIT

Evotec has wrapped up a deal for Sanofi's infectious disease unit. The agreement sees Sanofi transfer 100 employees, more than 10 drug...

Pharma giants like Novartis, Pfizer, and Sanofi are getting serious about a cutting edge therapy that changes human genes

PHARMA GIANTS LIKE NOVARTIS, PFIZER, AND SANOFI ARE GETTING SERIOUS ABOUT A CUTTING EDGE THERAPY THAT CHANGES HUMAN GENES

Pharma is getting serious about gene therapy, one-time treatments that modify genes to potentially cure serious diseases. Novartis...

 
 
 
Ambien Maker Sanofi to Roseanne Barr: No, Our Sleeping Pill Doesn't Cause Racism

AMBIEN MAKER SANOFI TO ROSEANNE BARR: NO, OUR SLEEPING PILL DOESN'T CAUSE RACISM

Roseanne Barr just got some epic Twitter shade from... one of the world's largest pharmaceutical companies. French drug giant Sanofi...

 
 
 
Roseanne blames Ambien for her racist tweet - but Ambien-maker says racism 'is not a known side effect' of its medications

ROSEANNE BLAMES AMBIEN FOR HER RACIST TWEET - BUT AMBIEN-MAKER SAYS RACISM 'IS NOT A KNOWN SIDE EFFECT' OF ITS MEDICATIONS

ABC Roseanne, the star of the now-canceled eponymous sitcom "Roseanne," blamed Ambien for her tweet comparing former Obama advisor...

Ambien maker trolls Roseanne Barr on Twitter

AMBIEN MAKER TROLLS ROSEANNE BARR ON TWITTER

"While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication,” the pharmaceutical...

 
 
 

LOOKING TO UNSEAT SANOFI AND SHIRE DRUGS, ATLAS GENE THERAPY STARTUP AVROBIO FILES FOR $86M IPO

Avrobio has filed for an $86.25 million IPO. The offering would give the Atlas Venture-backed startup the means to run clinical trials...

 
 
 
Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More

BIO ROUNDUP: DIY BIOHACKING, PCSK9 DATA, SOLID SETBACK & MORE

Drug prices are top of mind for many patients. Some of them have to cut back on basic needs just to pay for treatments that seem to...

 
 
 
Anatomy of two biotech deals worth $20B

ANATOMY OF TWO BIOTECH DEALS WORTH $20B

Analysts had forecast a blockbuster year for life science M&As, with the tax reforms taking effect and Big Pharma scrambling for late-stage...

 
 
 
WALL STREET PAYDAY: 4 banks made a killing from Monday's $20 billion in biotech deals

WALL STREET PAYDAY: 4 BANKS MADE A KILLING FROM MONDAY'S $20 BILLION IN BIOTECH DEALS

Biotech mergers and acquisitions are off to a hot start in 2018. On Monday, French drugmaker Sanofi spent $11.6 billion to buy US hemophilia...

Two drug companies are exploding after a pair of biotech mega-deals

TWO DRUG COMPANIES ARE EXPLODING AFTER A PAIR OF BIOTECH MEGA-DEALS

Markets Insider French drugmaker Sanofi is acquiring biotech company Bioverativ in a $11.6 billion deal. Celgene is acquiring Juno...

 
 
 
Sanofi is buying Bioverativ for $11.6 billion

SANOFI IS BUYING BIOVERATIV FOR $11.6 BILLION

Benoit Tessier/Reuters French drugmaker Sanofi is acquiring biotech company Bioverativ in a $11.6 billion deal. It's the biggest deal...

DEVELOPING A SANOFI CAST-OFF, IMPACT BIOMEDICINES NOW SUBJECT OF RUMORED $7B CELGENE ACQUISITION DEAL

A startup developing the once-discarded fedratinib, a drug cast off from Sanofi due to safety concerns back in 2013, is now the subject...

 
 
 

2 UNDERAPPRECIATED BIOTECH STOCKS TO BUY IN 2018

Why Horizon Pharma and Sanofi are three cheap stocks worth considering in 2018.